Incannex Healthcare (NASDAQ: IXHL) Stock: FDA Fast Track Catalyst, Nasdaq Compliance Clock, and the Latest Forecasts as of Dec. 15, 2025

Incannex Healthcare Inc. is back on traders’ radar heading into mid-December, with the stock hovering around $0.42 in early Monday pricing on December 15, 2025, after closing near $0.40 in the prior session.

15 December 2025

NASDAQ:IXHL · Stock Market

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2 data in sleep apnoea and psilocybin-assisted therapy, a major clean-up of warrant overhang, and a fight to keep the company’s Nasdaq listing alive. SEC+1

4 December 2025

NASDAQ:IXHL·Stock Market

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

TechStock² Updates

Aon’s $17 Billion Sale of USI Highlights 5.7x Sales Multiple

Nu Stock Falls 3.9%, Erasing $2.8 Billion as 6.9% NPL Rate Tests Credit Growth

Nokia Shares Drop 3.6%, Wiping Out $2.2 Billion as Rate Concerns Pressure 26x Earnings Multiple

UiPath Shares Edge Down 1.0% as Options Market Expects 11% Post-Earnings Move

American Airlines Shares Fall 0.6% While Carrier Adds Seven Routes, Faces 2.7% Operating Margin Pressure

PayPal Stock Falls 12.7%, Erasing $6.9 Billion as $53 Billion Bid Collapses

Circle’s $73.7 Billion USDC Gains International Visibility With Chelsea Shirt Sponsorship

Marvell Shares Drop 10.3%, Wiping Out $22 Billion After Google AI Revenue Delayed Beyond 2029

Ondas Shares Drop 9.7% After Reporting $50.6 Million EBITDA Loss Despite $757 Million Backlog

IREN shares drop 12.5% after $4 billion AI contract announcements coincide with $703 million annual loss

Investment Disclaimer